SEC Comment Letter for Aptose Biosciences Inc. (CIK 0000882361) (APTOF) — Jan 4, 2008

Aptose Biosciences Inc. (CIK 0000882361)
Date: Jan. 4, 2008 · CIK: 0000882361 · Accession: 0000000000-08-000646

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-32001

Date

January 4, 2008

Author

Not clearly detected

Form

UPLOAD

Company

Aptose Biosciences Inc. (CIK 0000882361)

Letter

Mail Stop 6010 Via Facsimile and U.S. Mail January 4, 2008

Ms. Aiping H. Young President and Chief Executive Officer Lorus Therapeutics, Inc. 2 Meridian Road Toronto, Ontario, Canada M9W 4Z7 Re: Lorus Therapeutics, Inc. Form 20-F for fiscal year ended May 31, 2006 File No. 001-32001 Dear Ms. Young:

We have completed our review of your Form 20-F and have no further comments at this time. S i n c e r e l y , Jim B. Rosenberg Senior Assistant Chief Accountant

Show Raw Text

Mail Stop 6010 Via Facsimile and U.S. Mail                                                                                                  January 4, 2008

Ms. Aiping H. Young President and Chief Executive Officer Lorus Therapeutics, Inc.  2 Meridian Road Toronto, Ontario, Canada M9W 4Z7
Re:      Lorus Therapeutics, Inc.
Form 20-F for fiscal year ended May 31, 2006
            File No. 001-32001
Dear Ms. Young:

We have completed our review of your Form 20-F and have no further comments
at this time.
       S i n c e r e l y ,
   Jim B. Rosenberg Senior Assistant Chief Accountant

SecProbe.io